Moderator: Igor Nikolic

Dr. Igor Nikolic is a Research Fellow at European University Institute, Italy. He specialises and writes in the areas of standard essential patents, innovation and technical standardisation, intellectual property and competition law. He published a book ‘Licensing Standard Essential Patents: FRAND and the Internet of Things’ (Hart Publishing 2021) examining the law, policy, and economics of SEP licensing. At EUI he gives lectures on patent licensing and 5G policy issues. Igor has given presentations at various international conferences and published in academic journals on different topics related to standardisation, FRAND commitment, SEP disputes, the appropriate level chain for licensing and licensing negotiations groups.

He obtained PhD at University College London, where he is also associated as a Senior Fellow at UCL’s Centre for Law, Economics & Society. He taught competition and IP law at UCL, King’s College and the University of Turin and worked as an external consultant for the World Bank. Igor is also a qualified attorney at law advising on competition, intellectual property and regulatory issues.

U.S. Universities: Engines of Economic Growth

By Sujai Shivakumar, Charles Wessner, Chris Borges, and Shruti Sharma Universities are among the United States’ most enduring sources of competitive advantage and a key pillar of the nation’s innovation system. Home to more than 35 of the world’s top 100 research universities, the United States owes many of its most
Read More

Andrei Iancu – Congressional Testimony: Hearing on the Patent Eligibility Restoration Act (PERA)

On October 8th, 2025, Andrei Iancu testified before the Senate Judiciary Committee, Subcommittee on Intellectual Property during the Hearing on the Patent Eligibility Restoration Act (PERA). Iancu, Partner at Sullivan & Cromwell, former Under Secretary of Commerce for IP and Director of the U.S. Patent and Trademark Office (USPTO), and
Read More

How Europe Lost Global Biopharmaceutical R&D Leadership to the United States: Lessons for Today

By Anne Prichett Today, the United States leads the world in biopharmaceutical industry research and development (R&D), supporting nearly five million jobs and generating more than $1.65 trillion in economic output. This position of global leadership, however, is relatively recent. Until the late 1980s, Europe–particularly Germany, France,
Read More